Citadel Advisors’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-603,600
| Closed | -$51.3M | – | 10610 |
|
|
2019
Q4 | $51.3M | Buy |
603,600
+10,600
| +2% | +$707K | 0.02% | 760 |
|
|
2019
Q3 | $29.6M | Buy |
593,000
+308,800
| +109% | +$12.3M | 0.01% | 1136 |
|
|
2019
Q2 | $10.4M | Buy |
284,200
+39,800
| +16% | +$1.3M | ﹤0.01% | 2135 |
|
|
2019
Q1 | $6.83M | Buy |
244,400
+23,200
| +10% | +$547K | ﹤0.01% | 2553 |
|
|
2018
Q4 | $4.23M | Buy |
221,200
+25,600
| +13% | +$596K | ﹤0.01% | 3020 |
|
|
2018
Q3 | $5.85M | Buy |
195,600
+108,800
| +125% | +$4.1M | ﹤0.01% | 2788 |
|
|
2018
Q2 | $3.19M | Buy |
86,800
+53,400
| +160% | +$1.74M | ﹤0.01% | 3392 |
|
|
2018
Q1 | $1.1M | Sell |
33,400
-47,300
| -59% | -$1.48M | ﹤0.01% | 4674 |
|
|
2017
Q4 | $2.21M | Buy |
80,700
+11,700
| +17% | +$360K | ﹤0.01% | 3502 |
|
|
2017
Q3 | $2.56M | Buy |
69,000
+21,400
| +45% | +$789K | ﹤0.01% | 3116 |
|
|
2017
Q2 | $1.81M | Sell |
47,600
-23,400
| -33% | -$1.04M | ﹤0.01% | 3304 |
|
|
2017
Q1 | $3.47M | Buy |
71,000
+29,000
| +69% | +$1.32M | ﹤0.01% | 2436 |
|
|
2016
Q4 | $1.43M | Buy |
42,000
+4,800
| +13% | +$170K | ﹤0.01% | 3364 |
|
|
2016
Q3 | $1.4M | Sell |
37,200
-7,000
| -16% | -$264K | ﹤0.01% | 3415 |
|
|
2016
Q2 | $1.49M | Sell |
44,200
-12,000
| -21% | -$423K | ﹤0.01% | 3064 |
|
|
2016
Q1 | $1.78M | Buy |
56,200
+15,600
| +38% | +$509K | ﹤0.01% | 2774 |
|
|
2015
Q4 | $1.52M | Sell |
40,600
-5,200
| -11% | -$197K | ﹤0.01% | 3064 |
|
|
2015
Q3 | $1.74M | Sell |
45,800
-7,000
| -13% | -$246K | ﹤0.01% | 3121 |
|
|
2015
Q2 | $1.51M | Buy |
52,800
+33,800
| +178% | +$942K | ﹤0.01% | 3399 |
|
|
2015
Q1 | $532K | Sell |
19,000
-4,000
| -17% | -$112K | ﹤0.01% | 4803 |
|
|
2014
Q4 | $636K | Sell |
23,000
-6,600
| -22% | -$164K | ﹤0.01% | 4371 |
|
|
2014
Q3 | $661K | Sell |
29,600
-4,400
| -13% | -$112K | ﹤0.01% | 4248 |
|
|
2014
Q2 | $988K | Sell |
34,000
-8,900
| -21% | -$238K | ﹤0.01% | 3500 |
|
|
2014
Q1 | $1.22M | Buy |
42,900
+22,800
| +113% | +$754K | ﹤0.01% | 3190 |
|
|
2013
Q4 | $776K | Buy |
20,100
+3,500
| +21% | +$125K | ﹤0.01% | 3494 |
|
|
2013
Q3 | $556K | Sell |
16,600
-17,900
| -52% | -$570K | ﹤0.01% | 3693 |
|
|
2013
Q2 | $1.06M | Buy |
+34,500
| New | +$1.15M | ﹤0.01% | 3135 |
|
Other funds holding MDCO
Citadel Advisors's MDCO Position: Q1 2020 in Review
Citadel Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 195,601 shares — an estimated $16.6M sold.
Citadel Advisors first reported a position in MDCO in Q2 2013 and held it in 24 quarters. The position peaked at $27.2M in Q3 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Citadel Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Citadel Advisors sold 195,601 Medicines Co shares in Q1 2020, an estimated $16.6M.
- Citadel Advisors first reported a position in Medicines Co in Q2 2013 and held it in 24 quarters.
- Citadel Advisors's Medicines Co position peaked at $27.2M in Q3 2015.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.